Metabolic reprogramming-mediated by mTOR complexes implicates in orchestrating the interaction of TME components, particularly immune cells and neoplastic cells, suggesting the crucial role of PI3K/Akt/mTOR in the determination of tumor development, progression as well as drug resistance. This evidence concerns the gene AKT1 and neoplasm.